Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study
收藏DataCite Commons2025-11-17 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011769/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to demonstrate the treatment success of fexinidazole, at one year follow-up visit, in HAT stage 1 and early stage 2 patients.
提供机构：
Vivli
创建时间：
2025-09-10
